PRA partnered with the sponsor’s new pediatric oncology department on an innovative pediatric oncology program. The program provided early evaluation of oncology treatments on children with relapsed or refractory solid tumors, fulfilling an unmet need in the industry.

Early Phase Innovative Pediatric Oncology Program Achieves Successful First Multiple Solid Tumors Study

Explore related content and topics